Thromb Haemost 1995; 73(03): 386-391
DOI: 10.1055/s-0038-1653785
Original Articles
Clinical Studies
Schattauer GmbH Stuttgart

Magnetic Resonance Imaging of Deep Vein Thrombi Correlates with Response to Thrombolytic Therapy

Charles W Francis
2   The Hematology Unit, Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York, USA
,
Saara Totterman
1   The Department of Radiology, University of Rochester School of Medicine & Dentistry, Rochester, New York, USA
› Author Affiliations
Further Information

Publication History

Received08 August 1994

Accepted after resubmission 30 November 1994

Publication Date:
09 July 2018 (online)

Summary

Fibrinolytic therapy can result in rapid lysis of deep vein thrombi (DVT), but its use is limited by the failure of many patients to respond and by the increased risk of bleeding complications in comparison with anticoagulant therapy alone. Treatment could be improved by the ability to select patients most likely to respond. Since magnetic resonance (MR) imaging may be sensitive to thrombus age and structure, properties related to thrombolytic sensitivity, we have evaluated the ability of MR imaging to predict the response of DVT to thrombolytic therapy. Nine patients with venographically documented proximal DVT were treated with streptokinase, and MR imaging using a gradient recall echo sequence was performed before and after therapy. The proximal leg veins were divided into nine segments in each patient, and thrombus was present in 55 segments. The MR appearance of the thrombus in each segment was evaluated prior to therapy, and the amount of clot lysis was determined by comparing pre- and post-treatment MR images. MR imaging accurately identified thrombus in all cases in comparison with venography and also identified proximal extension into pelvic veins that was not identified venographically. Prior to treatment, the thrombus in eight of nine patients varied in appearance in different vein segments consistent with a course of progressive extension over time. Thrombi with low MR signal occurred more often in patients with symptoms of four days or less, and were also more common in partially occluded segments (10/12, 83%) than with total occlusion (7/43, 16%) (p < .001). Clot lysis correlated with the appearance of the thrombi occurring in 9/17 (53%) segments with a uniform low signal intensity compared to 2/38 segments (5%) with areas of high or intermediate intensity (p < .001). Clot lysis was also correlated with partial vein occlusion and with symptom duration of 4 days or less. However, even among partially occluded segments and in patients with shorter duration of symptoms, clot lysis occurred significantly more often in segments with low MR signal intensity. The association of low MR signal intensity with both shorter symptom duration and incomplete vein obstruction suggests that this appearance identifies newly formed thrombi which may be responsive to thrombolytic therapy. We conclude that MR imaging may be useful in predicting response and selecting patients for thrombolytic therapy.

 
  • References

  • 1 Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venour thrombosis. Am J Med 1984; 393-397
  • 2 Marder VJ, Sherry S. Thrombolytic therapy: current status. New Engl J Med 1988; 318: 1512-1520
  • 3 Francis CW, Marder VJ. Fibrinolytic therapy for venous thrombosis. Prog Cardiovasc Dis 1991; 34: 193-204
  • 4 Cohen MD, McGuire W, Cory DA, Smith JA. MR appearance of blood and blood products: An in vitro study. AJR 1986; 146: 1293-1297
  • 5 Blackmore CC, Francis CW, Bryant RG, Brenner B. Magnetic resonance imaging of blood and clots in vitro. Invest Radiol 1990; 25: 1316-1324
  • 6 Clark RA, Watanabe AT, Bradley Jr W, Roberts JD. Acute hematomas: Effect of deoxygenation, hematocrit, and fibrin-clot formation and retraction on T2 shortening. Radiology 1990; 175: 201-206
  • 7 Astedt B, Robertson B, Haeger K. Experience with standardized streptokinase therapy of deep venous thrombosis. Surg Gynecol Obstet 1974; 139: 387-388
  • 8 Seaman AJ, Common HH, Rösch J, Dotter CT, Porter JM, Lindell TD, Lawler WL, Schlueter WJ. Deep vein thrombosis treated with streptokinase or heparin. Angiology 1976; 27: 549-556
  • 9 Marder VJ, Soulen RL, Aticharakarn V, Budzynski AZ, Parulekar S, Kim JR, Edward N, Zahavi J, Algazy KM. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med 1977; 89: 1018-1029
  • 10 Theiss W, Wirtzfeld A, Fink U, Maubach P. The succcessrate of fibrinolytic therapy in fresh and old thrombosis of the iliac and femoral veins. Angiology 1983; 34: 61-69
  • 11 Braun IF, Hoffman Jr JC, Malko JA, Pettigrew RI, Danneis W, Davis PC. Jugular venous thrombosis: MR imaging. Radiology 1985; 157: 357-360
  • 12 Macchi PJ, Grossman RI, Gomori JM, Goldberg HI, Zimmerman RA, Bilaniuk LT. High field MR imaging of cerebral venous thrombosis. J Comp Asst Tomography 1986; 10: 10-15
  • 13 Atlas SW, Grossman RI, Goldberg HI, Hackney DB, Bilaniuk LT. Zimmerman RA Partially thrombosed giant intracranial aneurysms: correlation of MR and pathologic findings. Radiology 1987; 162: 111-114
  • 14 Zirnsky K, Markisz JA, Rubinstein WA, Cahill DT, Knowles RJ R, Auh YH, Morrison H, Kazam E. MR imaging of portal venous thrombosis: correlation with CT and sonography. AJR 1988; 150: 283-288
  • 15 Erdman WA, Weinreb JC, Cohen JM, Buja LM, Chanel C, Peshock RM. Venous thrombosis: Clinical experimental MR imaging. Radiology 1986; 161: 233-238
  • 16 Rapoport S, Sostman HD, Pope C, Camputaro CM, Holcomb W, Gore JC. Venous clots: Evaluation with MR imaging. Radiology 1987; 162: 527-530
  • 17 Erdman WA, Jayson HT, Redman CH, Miller GL, Parkey RW. Peshock RW Deep venous thrombosis of extremities: Role of MR imaging in the diagnosis. Radiology 1990; 174: 425-431
  • 18 Thulbom KR, Waterton JC, Matthews PM, Radda GK. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta 1982; 714: 265-270
  • 19 Gilles P, Koenig SH. Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite. Magn Reson Med 1987; 5: 323-345
  • 20 Bryant RG, Marill K, Blackmore C, Francis C. Magnetic relaxation in blood and blood clots. Magn Reson Med 1990; 13: 133-144
  • 21 Gomori JM, Grossman RI, Goldberg HI, Zimmerman RA, Bilaniuk LT. Intracranial hematomas: imaging by high-field MR. Neuroradiology 1985; 157: 87-93
  • 22 Swensen SJ, Keller PL, Berquist TH, McLeod RA, Stephens PH. Magnetic resonance imaging of hemorrhage. AJR 1985; 145: 921-927
  • 23 Hahn PF, Saini S, Stark DD, Papanicolaou N, Ferrucci JT. Intraabdominal hematoma: the concentric-ring sign in MR imaging. AJR 1987; 148: 115-119
  • 24 Rubin JZ, Gomori JM, Grossman RZ, Gefler WB, Kressel HY. High field MR imaging of extracranial hematomas. AJR 1987; 148: 813-817
  • 25 Ebisu T, Naruse S, Horikawa Y, Tanaka C, Higuchi T. Nonacute subdural hematoma: fundamental interpretation of MR images based on biochemical and in vitro MR analysis. Neuroradiology 1989; 171: 449-453
  • 26 Théry C, Bauchart J, Lesenne M, Asseman P, Flajollet J-G, Legghe R, Marache P. Predictive factors of effectiveness of streptolkinase in deep venous thrombosis. Am J Cardiol 1992; 69: 117-122
  • 27 Mavor GE, Bennett B, Galloway JM D, Karmody AM. Streptokinase in iliofemoral venous thrombosis. Br J Surg 1969; 56: 564-570
  • 28 Elliot MS, Immelman EJ, Jeffrey P, Benatar SR, Funston MR, Smith JA, Shepstone BJ, Ferguson AD, Jacobs P, Walker W, Louw JH. A comparatiave randomized trial of heparin versus streptokinase inthe treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg 1979; 66: 838-843
  • 29 Verhaeghe R, Besse P, Bounameaux H, Marbet GA. Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosisof the lower extremities and/or pelvis. Thromb Res 1989; 56: 5-11
  • 30 Arnesen H, Heilo A, Jakobsen E, Ly B, Skaga E. A prospective study of streptokinase and heparin in the treatment of deep vein thrombosis. Acta Med Scand 1978; 203: 457-463
  • 31 Kakkar VV, Flanc C, Howe CT, Clarke MR. Natural history of postoperative deep-vein thrombosis. Lancet 1969; 2: 230-232
  • 32 Spritzer CE, Sussman SK, Blinder RA, Saeed M, Herfkens RJ. Deep venous thrombosis evaluation with limited-flip-angle, gradient-refocused MR imaging: Preliminary experience. Radiology 1988; 166: 371-375
  • 33 Totterman S, Francis CW, Foster TH, Brenner B, Marder VJ, Bryant RG. Diagnosis of femoropopliteal venous thrombosis with MR imaging: A comparison of four MR pulse sequences. AJR 1990; 154: 175-178
  • 34 Evans AJ, Sostman HD, Knelson MH, Spritzer CE, Newman GE, Paine SS, Beam CA. Detection of deep venous thrombosis: Prospective comparison of MR imaging with contrast venography. AJR 1993; 161: 131-139
  • 35 Spritzer CE, Norconk Jr JJ, Sostman HD, Coleman RE. Detection of deep venous thrombosis by magnetic resonance imaging. Chest 1993; 104: 54-60